Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Connolly

Showing results (351-360 of 380) with videos related to

Pageof 38
Sort By:
Plos One|November 9, 2013
Enhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccineDavid A G Skibinski, Brendon J Hanson, Yufang Lin, et al.
Lancet (London, England)|April 28, 2023
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trialHarry P Erba, Pau Montesinos, Hee-Je Kim, et al.
Virchows Archiv : an International Journal of Pathology|March 10, 1999
Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening PathologyJ P Sloane, I Amendoeira, N Apostolikas, et al.
Future Oncology (London, England)|July 11, 2026
QuANTUM-Wild: a Phase III, randomized trial of quizartinib in newly diagnosed <i>FLT3</i>-ITD-negative acute myeloid leukemiaPau Montesinos, Jessica K Altman, Lars Bullinger, et al.
Plos Neglected Tropical Diseases|August 11, 2016
Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever PatientsCynthia Sung, Yuan Wei, Satoru Watanabe, et al.
Human Pathology|October 22, 1998
Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening PathologyJ P Sloane, I Amendoeira, N Apostolikas, et al.
Scientific Reports|December 22, 2018
Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza VaccineDavid A G Skibinski, Leigh Ann Jones, Yuan O Zhu, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2020
ARGONAUT II Study of the <i>In Vitro</i> Activity of Plazomicin against Carbapenemase-Producing Klebsiella pneumoniaeMichael R Jacobs, Caryn E Good, Andrea M Hujer, et al.
Journal of Clinical Pathology|January 31, 2006
The NHS breast screening programme (pathology) EQA: experience in recent years relating to issues involved in individual performance appraisalD M Parham, D Coleman, S Kodikara, et al.
Journal of Clinical Pathology|January 31, 2006
Impact of a national external quality assessment scheme for breast pathology in the UKI O Ellis, D Coleman, C Wells, et al.
Pageof 38

Showing results (351-360 of 380) with videos related to

Sort By:
Pageof 38
Plos One|November 9, 2013
Enhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccineDavid A G Skibinski, Brendon J Hanson, Yufang Lin, et al.
Lancet (London, England)|April 28, 2023
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trialHarry P Erba, Pau Montesinos, Hee-Je Kim, et al.
Virchows Archiv : an International Journal of Pathology|March 10, 1999
Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening PathologyJ P Sloane, I Amendoeira, N Apostolikas, et al.
Future Oncology (London, England)|July 11, 2026
QuANTUM-Wild: a Phase III, randomized trial of quizartinib in newly diagnosed <i>FLT3</i>-ITD-negative acute myeloid leukemiaPau Montesinos, Jessica K Altman, Lars Bullinger, et al.
Plos Neglected Tropical Diseases|August 11, 2016
Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever PatientsCynthia Sung, Yuan Wei, Satoru Watanabe, et al.
Human Pathology|October 22, 1998
Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening PathologyJ P Sloane, I Amendoeira, N Apostolikas, et al.
Scientific Reports|December 22, 2018
Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza VaccineDavid A G Skibinski, Leigh Ann Jones, Yuan O Zhu, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2020
ARGONAUT II Study of the <i>In Vitro</i> Activity of Plazomicin against Carbapenemase-Producing Klebsiella pneumoniaeMichael R Jacobs, Caryn E Good, Andrea M Hujer, et al.
Journal of Clinical Pathology|January 31, 2006
The NHS breast screening programme (pathology) EQA: experience in recent years relating to issues involved in individual performance appraisalD M Parham, D Coleman, S Kodikara, et al.
Journal of Clinical Pathology|January 31, 2006
Impact of a national external quality assessment scheme for breast pathology in the UKI O Ellis, D Coleman, C Wells, et al.
Pageof 38